Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
WAYCEN Inc
Eastern Cooperative Oncology Group
Emory University
Boston Scientific Corporation
Istituto Oncologico Veneto IRCCS
AstraZeneca
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Boehringer Ingelheim
AstraZeneca
AstraZeneca
Rigshospitalet, Denmark
National Cancer Institute (NCI)
Inhibrx Biosciences, Inc
Exelixis
AstraZeneca
Seattle Children's Hospital
Seattle Children's Hospital
Providence Health & Services
TScan Therapeutics, Inc.
AstraZeneca
M.D. Anderson Cancer Center
University of Kentucky
AstraZeneca
M.D. Anderson Cancer Center
Sichuan Baili Pharmaceutical Co., Ltd.
Washington University School of Medicine
Exelixis
Duke University
Nuvectis Pharma, Inc.
GlaxoSmithKline
Australasian Gastro-Intestinal Trials Group
Memorial Sloan Kettering Cancer Center
AstraZeneca
AstraZeneca